— Know what they know.
Not Investment Advice

ZY NASDAQ

Zymergen Inc.
1W: -8.7% 1M: -10.7% 3M: +13.0% 1Y: -80.7%
$2.43
Last traded 2022-10-18 — delisted
NASDAQ · Basic Materials · Chemicals - Specialty
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range1.1-11.87
Volume2,350,912
Avg Volume1,041,782
Beta0.00
Dividend—
Analyst Ratings
0 Buy 4 Hold 2 Sell
Consensus Hold
Company Info
CEOJoshua J. Hoffmann
Employees502
SectorBasic Materials
IndustryChemicals - Specialty
IPO Date2021-04-22
5980 Horton Street
EmeryVille, CA 94608
US
415 801 8073
About Zymergen Inc.

Zymergen Inc. specializes in the creation, advancement, and market introduction of various biological entities and substances, including microorganisms, specialized molecules, and novel materials. The company provides an advanced automation platform, which incorporates adaptable automation carts—modular hardware components enabling the construction of laboratory work cells tailored to specific research requirements. Additionally, it features cloud-based automation control software designed to manage integrated automated systems efficiently. Zymergen's diverse clientele spans sectors such as electronics, packaging, healthcare, agriculture, and others. Established in 2013, Zymergen Inc. is headquartered in Emeryville, California. Since October 19, 2022, the company has operated as a subsidiary under Ginkgo Bioworks Holdings, Inc.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
SVF Excalibur (Cayma J-Other 26,614,219 — 2022-10-19
FLATLEY JAY T D-Return 189,125 — 2022-10-19
Chu Steven D-Return 132,333 — 2022-10-19
PETERSON SANDRA E D-Return 133,333 — 2022-10-19
Murdoch Travis D-Return 79,697 — 2022-10-19

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms